Expert Insights on the Key Role of Biostimulatory Fillers in Aesthetic Medicine - Submalar - 52 YO Female

Expert Insights on the Key Role of Biostimulatory Fillers in Aesthetic Medicine - Submalar - 52 YO Female

 

Release Date: September 10, 2018

Last Reviewed: July 28, 2018

Expiration Date: September 10, 2021

Time to Complete Each Activity: 5-15 minutes
*This activity expired for credit on September 10, 2021 and is no longer available for credit
 

This activity is provided by Paradigm Medical Communications, LLC. 

As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 

Clinicians in aesthetic medicine face the constant challenge of keeping ahead of the curve with evolving techniques and a broadening array of available products. This activity will provide participants with expert recommendations on the use of biostimulatory fillers and how to apply best practices for aesthetic medicine, including integration of novel approaches and individualization based on anatomic assessment, extent of aging, and patient goals.

This activity has been designed to meet the educational needs of dermatologists, plastic surgeons, facial plastic surgeons, ocular plastic surgeons, and ophthalmologists. It may also be of benefit to nurses and other healthcare providers who are involved in the field of aesthetic medicine.

 

Upon proper completion of this activity, participants should be better able to:

 

Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

PAs may claim a maximum of 0.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. 
 

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 

This activity is supported by an educational grant from Galderma Laboratories, L.P.

 

To receive a CME certificate of participation, you should:

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

 

There is no fee required for participation in this activity.

 

Once you complete an activity, you will be able to re-watch the video at any time.
1. To access the video again, click on “My Courses” at the top of your screen before closing the activity window, or visit www.paradigmmc.com/transcript at any time
2. If you are not already logged in, you will need to enter your email address and password
3. Click on the “Content” button to the right of the video you want to re-watch

This certified CME activity is designed using HTML5 video.

 

For Desktops (Windows/Mac)

Internet Explorer 9 or higher, Firefox 28 or higher, Safari 8 or higher, Google Chrome 31 or higher, Opera 21 or higher

 

For Tablets (iPad/Android/Surface)

iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 

Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.

 

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

Medical Director

Shino Bay Cosmetic Dermatology, Plastic Surgery & Laser Institute

Fort Lauderdale, FL

Consultant: Allergan, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; SkinCeuticals International; Valeant Pharmaceuticals International, Inc

 

Volunteer Assistant Clinical Professor

Department of Medicine/Dermatology

University of California, San Diego

Goldman Butterwick Fitzpatrick Groff and Fabi Cosmetic Laser Dermatology

San Diego, CA

Consultant: Alastin Skincare, Inc; Allergan, Inc.; Colorscience, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc

Speakers’ Bureau: Alastin Skincare, Inc; Allergan, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.

Grant/Research Support: Alastin Skincare, Inc; Allergan, Inc.; Ampersand Aesthetics; Bayer HealthCare; Colorscience, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc

Stockholder: Allergan, Inc.; Revance Therapeutics, Inc

 

Private Practice

Los Angeles, CA

Advisory Board: Allergan, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.

Speakers’ Bureau: Allergan, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.

 

Skin Laser and Surgery Specialists of NY & NJ

New York, NY

Advisory Board: Aerolase Corp.; Almirall, S.A.; Erchonia Corporation; Ferndale Labs, Inc.; Galderma Laboratories, L.P.; Johnson & Johnson Services, Inc; LEO Pharma Inc; Lutronic; Merz North America, Inc.; Neothetics, Inc; Sienna Biopharmaceuticals, Inc.; Sinclair Pharma; Thermi

Contracted Research: Aerolase Corp.; Allergan, Inc.; Alma Lasers; Anacor Pharmaceuticals, Inc; Cutera; Galderma Laboratories, L.P.; inmode; LEO Pharma Inc; Noven Pharmaceuticals, Inc.; Sebacia, Inc; Sensus Healthcare; Sienna Biopharmaceuticals, Inc.; Syneron Candela

Speakers’ Bureau: Allergan, Inc.; Alma Lasers; EndyMed Medical Ltd; Merz North America, Inc.; Suneva Medical, Inc

Stockholder: Aerolase Corp.; Aquavit Pharmaceuticals, Inc.; Strathspey Crown

 

Assistant Clinical Professor

Department of Head and Neck Surgery

University of California Los Angeles

Los Angeles, CA
Director, Clinical Testing of Beverly Hills

John H. Joseph, MD

Beverly Hills, CA

Advisory Board: Allergan, Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.

Contracted Research: Alphaeon Corporation; Ampersand Aesthetics; Chroma Technology Corporation; Endo International Pharmaceuticals; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc; RXI Pharmaceuticals Corporation; Teoxane Laboratories; Ulthera, Inc

Speaker: Galderma Laboratories, L.P.

Stockholder: Alphaeon Corporation; Endo International Pharmaceuticals; Evolus; Revance Therapeutics, Inc; Skin Vent; Suneva Medical, Inc; Valeant Pharmaceuticals International, Inc

 

Medical Director

Lorenc Aesthetic Plastic Surgery Center

Department of Plastic Surgery

Lenox Hill Hospital

New York, NY

Consultant: Allergan, Inc.; Galderma Laboratories, L.P.; Johnson & Johnson Services, Inc; Merz North America, Inc.; Sinclair Pharma; Suneva Medical, Inc; Thermi

 

Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

 

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

 

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

 

If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.

 

The materials provided for this activity are for informational purposes only and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.

 

Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

 

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

 

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.

 

Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.

 

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.

 

© 2018 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.